South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

It has been estimated that the human immune system can produce up to 1 quintillion different antibodies by changing the ...

The sequence homology is over 95%; PTM and aggregation prediction reports are also available 100% success rate As quick as 3–4 weeks to offer required humanized antibodies Affinity evaluated by ...

The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...

The process is followed by computationally guided mutagenesis or evolution of the antibody sequence (hit to lead, or H2L, optimisation) to improve the binding and other properties. Although the ...

Beginning from the antibody sequence or customer’s cDNA, Sino Biological offers cell line development services varying from expression vector construction to screening for stable cell lines and ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...

Monoclonal antibodies are considered the most rapidly growing class of therapeutics. Critical quality attributes such as sequence assessment, charge and size variants must be thoroughly monitored ...